Sector GlaxoSmithKline Pharmaceuticals Limited

Aandelen

GLAXO

INE159A01016

Farmaceutische producten

Beurs gesloten - 12:02:24 13-10-2026 Variatie 5 dagen Verschil t.o.v. 1 jan (%)
2.534,00 INR +0,10% Intraday-grafiek van GlaxoSmithKline Pharmaceuticals Limited -8,13% +2,55%
Belangrijkste concurrenten
Verschil (%) Varia. 5d. Evolutie 1 maand Evolutie 3 maanden Var. 1 jan Varia. 1j. Varia. 3j. Varia. 5j. Varia. 10j. Kap.($)
+0,10%-8,13%-9,95%+4,83%+2,55%-7,89%+65,98%+71,55%+73,26% 4,49 mld.
-0,68%+1,65%+3,37%-0,44%+9,49%+43,60%+93,15%+397,65%+1.370,80% 1.054 mld.
-5,16%-1,01%-5,30%-2,16%+21,87%+32,11%+60,79%+58,42%+113,26% 636 mld.
-1,18%+4,33%+6,29%+12,20%+21,78%+20,82%+88,05%+156,38%+355,02% 497 mld.
-1,26%+1,48%-0,56%+16,13%+36,84%+68,07%+38,49%+82,44%+130,43% 359 mld.
+0,19%+3,32%0,00%+9,28%+10,12%+24,58%+41,70%+1,20%+54,44% 345 mld.
-0,33%+2,32%+5,25%-3,76%+9,40%+14,74%+37,00%+56,73%+60,83% 273 mld.
-0,42%+0,28%-1,33%-4,90%-13,04%-5,75%+9,28%+35,43%+142,24% 246 mld.
-0,62%+2,93%+8,63%+14,97%+26,61%+41,72%+45,87%+103,53%+152,24% 226 mld.
-1,23%+3,08%+1,54%+13,14%+21,13%+25,77%+91,46%+119,83%+103,49% 187 mld.
-0,10%+4,44%-8,54%-20,95%-21,15%-31,35%-64,21%-20,36%+93,04% 169 mld.
-0,90%+2,84%+2,02%+15,52%+13,57%+14,36%-11,93%-31,72%-13,68% 162 mld.
-2,42%-1,39%-4,65%+3,14%+9,26%+21,59%+33,51%+173,15%+514,86% 129 mld.
-2,12%-5,44%-12,09%-5,04%+4,47%+29,42%-0,21%-1,26%+12,16% 118 mld.
+0,35%+3,71%+4,93%+17,68%+16,53%+24,23%+106,65%+379,72%+489,81% 111 mld.
-1,06%+0,30%-6,11%-8,15%-14,39%-15,85%-31,50%-15,22%+3,90% 95,82 mld.
-0,71%-0,20%-4,99%-9,80%-3,43%+8,26%+16,69%+0,61%-17,08% 93,75 mld.
-0,24%+10,26%+40,90%+208,45%+600,88%+672,96%+110,26%-35,71% - 85,33 mld.
-2,12%+0,92%-6,08%+12,43%-3,42%+33,66%-11,21%+36,26%+98,38% 76,17 mld.
+0,11%+0,22%+6,70%-0,39%+13,62%+18,30%-7,41%-27,26%+46,20% 67,34 mld.
Gemiddelde -0,97%+2,32%+1,00%+13,61%+38,13%+51,67%+35,62%+77,07%+199,14% 246,7 mld.
Gewogen gemiddelde per kap. -1,32%+3,04%+1,26%+7,01%+22,93%+39,08%+52,46%+139,15%+414,49%
  1. Beurs
  2. Aandelen
  3. Koers GLAXO
  4. Sector GlaxoSmithKline Pharmaceuticals Limited